Researcher
Geert ROBAEYS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Immunology not elsewhere classified
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Aug 2009 → Today - Immunology - Biochemistry (Research group)
Member
From1 Sep 2012 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Aug 2009 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Aug 2009 → 30 Sep 2009
Projects
1 - 5 of 5
- The effectiveness and cost-efficacy of different guidance methods to facilitate lifestyle changes in the treatment of NAFLDFrom1 Oct 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- : Development of an evidence based proof of concept care path for Non-Alcoholic Fatty Liver disease in Flanders.From1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project
- Viral hepatitis B in EU regional setting: prevalence, risk factors and disease progression among migrants.From1 Oct 2016 → 30 Sep 2020Funding: BOF - Doctoral projects
- HCV treatments as prevention in Europe: model projections of impact and strengthening evidence base on intervention coverage and effect and HCV morbidityFrom27 Jun 2014 → 30 Sep 2015Funding: Other EU initiatives out of framework, Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 78
- A long-term study of liver-related events in Caucasian hepatitis B patients with normal ALT values and high viremia(2022)
Authors: Ozgur KOC, J. Verbeek, G. H. Koek, Rob BIELEN, Dana BUSSCHOTS, M. Gamil, Geert ROBAEYS, F. Nevens
Pages: 56 - 61 - The fibrosis-4 cut-off value for significant fibrosis is dependent on the type of non-alcoholic fatty liver disease patients(2022)
Authors: Leen HEYENS, Wouter ROBAEYS, Christophe Van Steenkiste, Sven Francque, Geert ROBAEYS
Pages: S459 - S460 - Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis(2022)
Authors: Dana BUSSCHOTS, Cecile KREMER, Rob BIELEN, Ozgur KOC, Leen HEYENS, Frederik Nevens, Niel HENS, Geert ROBAEYS
- Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study(2022)
Authors: Sarah Blach, Norah A. Terrault, Frank Tacke, Ivane Gamkrelidze, Antonio Craxi, Junko Tanaka, Imam Waked, Gregory J. Dore, Zaigham Abbas, Ayat R. Abdallah, et al.
Pages: 396 - 415 - Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach(2022)
Authors: Dana BUSSCHOTS, Erwin Ho, Sarah Blach, Frederik Nevens, Homie Razavi, Ilse Van Damme, Thomas Vanwolleghem, Geert ROBAEYS
- Evaluation of the Fibrosis-4 score for referral from primary care patients for NAFLD in Belgium(2021)
Authors: Leen HEYENS, Dana BUSSCHOTS, Judith Wellens, Marlies Devos, Luc Present, Brigitte Schoenmakers, Kitty De Munck, Eva Rubens, Katrien Joris, Roy Remmen, et al.
Pages: S581 - S582 - Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in Belgium(2021)
Authors: Dana BUSSCHOTS, Amber ARAIN, Rob BIELEN, Ozgur KOC, Liesbeth BRUCKERS, Trias Wahyuni RAKHMAWATI, Kristoff CORTEN, C Lebbe, K Cornelis, C Mathei, et al.
Pages: 311 - 316 - A multicentre interventional study to assess blood-borne viral infections in Belgian prisons(2021)
Authors: Dana BUSSCHOTS, Cecile KREMER, Rob BIELEN, Ozgur KOC, Leen HEYENS, C Brixko, P Laukens, H Orlent, P Bilaey, F De Smet, et al.
- On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era(2021)
Authors: Dana BUSSCHOTS, Rob BIELEN, Ozgur KOC, Leen HEYENS, Rita Verrando, Filip Janssens, Peter Van Lint, Liesbeth BRUCKERS, Frederik Nevens, Geert ROBAEYS, et al.
- Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium(2021)
Authors: Leen HEYENS, Dana BUSSCHOTS, Judith Wellens, Marlies Devos, Luc Present, Birgitte Schoenmakers, Kitty De Munck, Eva Rubens, Katrien Joris, Roy REMMEN, et al.
Pages: 30 - 31
Linked dataset
1 - 1 of 1